DAVITA INC. Deferred Federal Income Tax Expense (Benefit)
DAVITA INC. (DVA) reported Deferred Federal Income Tax Expense (Benefit) of $76.51 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-11
- DAVITA INC. deferred federal income tax expense (benefit) for fiscal 2025 was $76.51M.
- DAVITA INC. deferred federal income tax expense (benefit) for fiscal 2024 was -$47.72M.
- DAVITA INC. deferred federal income tax expense (benefit) for fiscal 2023 was -$40.23M.
- DAVITA INC. deferred federal income tax expense (benefit) for fiscal 2022 was -$66.40M, a 211.54% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $76.51M 10-K · filed 2026-02-11 | |
| 2024-12-31 | -$47.72M 10-K · filed 2026-02-11 | |
| 2023-12-31 | -$40.23M 10-K · filed 2026-02-11 | |
| 2022-12-31 | -$66.40M 10-K · filed 2025-02-13 | |
| 2021-12-31 | $59.53M 10-K · filed 2024-02-14 | |
| 2020-12-31 | $198.62M 10-K · filed 2023-02-22 | |
| 2019-12-31 | $44.26M 10-K · filed 2022-02-11 | |
| 2018-12-31 | $52.03M 10-K · filed 2021-02-12 | |
| 2017-12-31 | -$98.76M 10-K · filed 2020-02-21 | |
| 2016-12-31 | $88.41M 10-K · filed 2019-02-22 | $93.21M 10-K · filed 2017-02-24 |
| 2015-12-31 | $71.02M 10-K · filed 2018-02-23 | $88.72M 10-K · filed 2016-02-26 |
| 2014-12-31 | $192.27M 10-K · filed 2017-02-24 | |
| 2013-12-31 | -$6.70M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $64.19M 10-K · filed 2015-02-26 | $41.42M 10-K · filed 2013-03-01 |
| 2011-12-31 | $63.66M 10-K · filed 2014-02-21 | $46.78M 10-K · filed 2012-02-24 |
| 2010-12-31 | $67.90M 10-K · filed 2013-03-01 | |
| 2009-12-31 | $44.38M 8-K · filed 2012-07-06 | |
| 2008-12-31 | $81.31M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |